- Service category
- Partnering/collaboration for drug dossiers, patents, drug candidates, medical technology
Your company? Get access to this profile.
MotilityCount’s new home sperm test will be distributed and marketed in collaboration with leading diagnostic companies.
The product is currently under development and will be ready for commercial launch globally during the first half of 2013.
Interested companies with the right match of competencies (strong local presence especially in regards to marketing diagnostic kits via pharmacies) are welcome to contact MotilityCount for further information.
You might be also interested in
Sourcing this company's services?Send inquiry anonymously »